Navigation Links
MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production
Date:8/23/2007

GAITHERSBURG, Md., Aug. 23 /PRNewswire/ -- MedImmune, Inc. announced today that it has licensed its proprietary reverse genetics intellectual property to Novartis to support the development and construction of new vaccine strains to produce inactivated human seasonal, pre-pandemic and pandemic influenza vaccines. Reverse genetics is a method by which viruses such as influenza can be generated from segments of DNA. For prospective pandemic influenza vaccines, reverse genetics can be a useful technology because the process does not require manufacturers to work directly with potentially highly infectious pandemic strains, such as H5N1, rather only segments of the virus's genome.

Most influenza vaccine manufacturing companies and governmental agencies are now using reverse genetics technology in their development of pandemic vaccine candidates because it allows them to avoid working directly with the infectious, circulating pandemic strains. As the owner or exclusive licensee of the key patent estates for use of the reverse genetics technology in human influenza vaccines, MedImmune remains committed to making sure that the technology is accessible to government institutions and industry manufacturers. As such, the company has offered other influenza vaccine manufacturers non-exclusive licenses to this intellectual property estate for use in manufacturing seasonal or pandemic vaccines.

"MedImmune is pleased to have now entered into reverse genetics licensing agreements with three leaders in influenza vaccine development and manufacturing," said Jonathan Klein-Evans, J.D., MedImmune's vice president, intellectual property. "With each new license that expands access to this important technology, the world is advancing its pandemic preparedness as we apply new tools such as reverse genetics to improve and streamline the influenza vaccine development process."

MedImmune will receive an upfront payment and has the potential to receive royalties on ce
'/>"/>

SOURCE MedImmune, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. GenTel licenses next generation cancer research
2. Third Wave licenses Innogenetics tech to settle lawsuit
3. WARF licenses patents for new glaucoma drug treatment
4. PKWARE Licenses Technology to Expand SecureZIP Standard
5. Mentor Licenses Botulinum From WARF and Plans Wisconsin Manufacturing Facility
6. Suggested applications for reverse transcriptases
7. Properties of Reverse Transcriptases
8. Reverse transcriptases suitable for one-step RT-PCRb
9. Reverse transcriptases suitable for two-step RT-PCRd
10. C. therm. Polymerase for Reverse Transcription in Two-Step RT-PCR
11. Choice of reverse transcription primers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2008)...NEAPOLIS, July 3 /- The Eniva Researc...g by the world-famous Linus Pauling,Micronutrient ...h,demonstrated the Eniva Health Supplement VIBE(R)...for human cells. This third party testing was,perf...o further identify,mechanisms by which the Eniva V...
(Date:7/3/2008)...SISSAUGA, ON, July 3 / Vaso...that it has implemented additional,restructuring p...iously,announced, the Company has been exploring s...cquisitions and mergers. In conjunction with this,...ve review of its VP,series of drugs, and has deter...
(Date:7/3/2008)... BRUNSWICK, N.J., July 3 /-...pany") (Amex: SNT ) announced today,that it has c...ance) to,supply Polyplus,s "in vivo-jetPEI" for sy...f siRNA against Factor 5A and a plasmid of the Fac...itive preclinical in vivo results,using its combin...
(Date:7/3/2008)...INE, Calif., July 3 /- Antigen Discov....), a leader in high throughput,antigen/biomarker ...ools,announced today that the Company was awarded...lergy and Infectious Diseases (NIAID) and the,Nati...million grant will,fund efforts to further develop...
Breaking Biology Technology:Eniva VIBE(R) Nutraceutical Tested at Linus Pauling Micronutrient Research Institute and Found to Possess DNA Protective Properties 2Vasogen Provides Corporate Update 2Senesco Signs a Supply Agreement for Polyplus-transfection's Delivery System 2Senesco Signs a Supply Agreement for Polyplus-transfection's Delivery System 3Senesco Signs a Supply Agreement for Polyplus-transfection's Delivery System 4Antigen Discovery Inc. Awarded a SBIR Phase II Grant to Commercialize Novel Antigens for Serodiagnostic Products and Vaccine Development 2
...he July 2006 edition of MedAd News sustains that...r. On Aug, 23, 2004, I wrote an article for this p...o, Boston, Geneva, or Chicago? " , ,In this articl... dates and commercial milestones that date the ind...tech and Amgen went public (1980). The authors of ...
...ral and man-made disasters, a Wisconsin truck manu...red business network. , ,The purchase will outfit ...cated networking solutions, including a single con... five years. , ,The solutions, provided by AT&T, ...ns companies, are intended to help preserve "missi...
...scles to focus on different distances. Man-made de...e sensors do not require these external controls. ...ison College of Engineering are investigating a l...ironmental changes and could be used in a variety ...nostic tools and life science sensor arrays. , ,Th...
... a crucial moment in the development of stem cell ...ers of human embryonic stem cell research to bring...this fall. , ,Doyle, speaking at a symposium of th...ink thank, said the reason the nation is at a crit...ant to see stem cell research stopped in it tracks...
Other Biology Technology:At 30, biotech is an industry at a crossroads 2At 30, biotech is an industry at a crossroads 3At 30, biotech is an industry at a crossroads 4At 30, biotech is an industry at a crossroads 5At 30, biotech is an industry at a crossroads 6At 30, biotech is an industry at a crossroads 7"Smart" lenses hold commercial potential 2Doyle says practical politics must advance embryonic stem cell research 2Doyle says practical politics must advance embryonic stem cell research 3
(Date:7/2/2008)...team has published the first clear example of how ...seases that are normally tolerated singly may conv..., In a report issued June 25 by PLoS ONE, an on...xamined outbreaks of canine distemper virus (CDV) ...ortality in Serengeti lions. CDV cycles periodical...
(Date:7/2/2008)...2, 2008) Led by a bold commitment from Germany, l...pportunity at the upcoming G8 Summit in Japan to t...te change. , German Chancellor Angela Merkel,s r...to conserve tropical forests, followed by increase...address a major source of greenhouse gas emissions...
(Date:7/2/2008)...ished online in The FASEB Journal provide more e...r intelligence can improve. According to MIT scien...foods from infant formula to eggs increase brain s...pe human brains will, like those of experimental a...g more brain synapses and thus restoring cognitive...
(Date:7/2/2008)... Florida State University faculty member who uses ...f cancer-killing drugs is attracting worldwide att...an assistant professor of chemical and biomedical ...State University College of Engineering, is using ... known as recombinant immunotoxins can best be mod...
Breaking Biology News(10 mins):G8 summit: Opportunity for immediate action on climate change 2G8 summit: Opportunity for immediate action on climate change 3FSU researcher using computers to hone cancer-fighting strategies 2Diabetic Food Shopping That Wont Break a Budget 16645 1Diabetic Food Shopping That Wont Break a Budget 16645 2Penn researchers find targeted therapy combination overcomes treatment resistance in liver cancer 16643 1Penn researchers find targeted therapy combination overcomes treatment resistance in liver cancer 16643 2Male Contraception 3A Progress Slow but Steady 16640 1Male Contraception 3A Progress Slow but Steady 16640 2Male Contraception 3A Progress Slow but Steady 16640 3National hospice study reveals gaps in service 16638 1National hospice study reveals gaps in service 16638 2National hospice study reveals gaps in service 16638 3National hospice study reveals gaps in service 16638 4
... embryos for genetic diseases during in vitro fert...lthy child, but a genetic glitch could potentially...them, University of Florida researchers say. , Ci...n genetic diagnosis, the method many practitioners... researchers set out to study the procedure. Their...
... cells that develop in the olfactory system of adu...nt from that of older neurons. The new olfactory ... preferentially learning to respond to new odors. ...y-generated neurons could be induced to adapt to a...aps allowing them to replace neurons lost to injur...
...Mukhopadhyay and Eric Johnson from the Virginia Bi...vered a novel enzyme that represents an ancient de...elopment of early metabolism on earth. , The resea...nal of Biological Chemistry, in the article "A New...dependent Enzyme, from the Methanoarchaeon Methano...
...s, the ability to accurately sense light governs e...d pigmentation to patterns of growth and flowering...ned a detailed map of one of biology,s most import...es across life,s plant, fungal, and bacterial king... of the protein known as phytochrome, scientists c...
Other Biology News:Genetic testing still smart choice, despite uncertainties 2Genetic testing still smart choice, despite uncertainties 3Neurons generated in the adult brain learn to respond to novel stimuli 2Novel protein complex enables survival in hostile environment 2Novel protein complex enables survival in hostile environment 3Novel protein complex enables survival in hostile environment 4Novel protein complex enables survival in hostile environment 5Scientists map one of biology's critical light-sensing structures 2Scientists map one of biology's critical light-sensing structures 3
...ector Sequencing Primer is designed for sequencing...s (Cat.# V2031, V2051, V2061). The primer hybridiz...25343, approximately 4050 base pairs upstream of t...rmine if an insert is cloned in-frame with the bio...
The versatile Zymo-Spin I-96 Plate can be used either in centrifuges or on vacuum manifolds for the large-scale (i.e., 96-well) purification of DNA and/or RNA. Its deep-well, durable polypropylene co
AdestaTM Tissue/Cell Preservation Medium Sterile / Non-sterile: Sterility Tested Endotoxin:
...he first all-inclusive collection of key procedure.... Methods developed by the leaders in Pichia expre...cols. This book will guide you from choosing the a...ruction and analysis, to production of your protei...
Biology Products: